Medpace Holdings earnings per share (EPS) for the twelve months ending March 31, 2025 was $13.10, a 33.54% increase year-over-year.
Medpace Holdings EPS for the quarter ending March 31, 2025 was $3.67, a 14.69% increase year-over-year.
Medpace Holdings 2024 annual EPS was $12.63, a 42.23% increase from 2023.
Medpace Holdings 2023 annual EPS was $8.88, a 21.98% increase from 2022.
Medpace Holdings 2022 annual EPS was $7.28, a 51.35% increase from 2021.
Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.